Maya D. M.
- Country
- Bulgaria
- Department
- Neurology Clinic - nervous diseases
Research Overview
- Phase 1b/2 Study of IM-101 in Adult Participants with Generalized and Ocular Myasthenia Gravis
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Phase III Randomized Double‑Blind Study of Fenebrutinib versus Teriflunomide for Efficacy and Safety in Adults with Relapsing Multiple Sclerosis
Data & Insights
Has run more than one trial at 374 of 662 partner sites.
Specializations
Multiple Sclerosis Treatment
Specializes in evaluating novel therapeutic approaches for relapsing multiple sclerosis (RMS) and progressive multiple sclerosis (PMS), with particular focus on investigating innovative treatments like ofatumumab, tolebrutinib, and frexalimab.
- Relapsing Forms Management
- Progressive Disease Treatment
- Brain Atrophy Prevention
Neurological Disorders
Conducts research in chronic inflammatory demyelinating polyneuropathy (CIDP) and progressive supranuclear palsy, focusing on innovative therapeutic approaches and long-term treatment outcomes.
- Inflammatory Neuropathies
- Neurodegenerative Conditions
- Disease Progression Monitoring
Cerebrovascular Medicine
Investigates treatments for acute ischemic stroke and transient ischemic attack, with emphasis on novel anticoagulation therapies including asundexian and milvexian for stroke prevention.
- Stroke Prevention
- Post-Stroke Care
- Anticoagulation Therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.